Recent developments in major pharmaceutical companies indicate a mixed outlook. Biogen's Leqembi shows promising sales, while Haleon and Novo Nordisk face setbacks due to weak U.S. demand and ...

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

Elon Musk’s brain-implant company Neuralink is expanding its human trials to the United Kingdom. The company announced on Thursday that it is launching a clinical study in collaboration with ...